Skip to Content

NeuroMetrix Inc NURO

Morningstar Rating
$3.98 +0.02 (0.45%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NURO is trading within a range we consider fairly valued.
Price
$3.93
Fair Value
$4.99
Uncertainty
Extreme
1-Star Price
$57.34
5-Star Price
$7.36
Economic Moat
Jybyk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NURO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$3.96
Day Range
$3.694.00
52-Week Range
$2.709.68
Bid/Ask
$3.10 / $4.78
Market Cap
$8.00 Mil
Volume/Avg
7,279 / 28,295

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.95
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
26

Valuation

Metric
NURO
Price/Earnings (Normalized)
Price/Book Value
0.42
Price/Sales
0.95
Price/Cash Flow
Price/Earnings
NURO

Financial Strength

Metric
NURO
Quick Ratio
9.78
Current Ratio
10.91
Interest Coverage
Quick Ratio
NURO

Profitability

Metric
NURO
Return on Assets (Normalized)
−32.96%
Return on Equity (Normalized)
−35.40%
Return on Invested Capital (Normalized)
−34.94%
Return on Assets
NURO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesNfmlqxvypHnzddf$177.4 Bil
SYK
Stryker CorpQrlfyhkwbhKpbc$127.8 Bil
BSX
Boston Scientific CorpHktglpncWfchz$110.5 Bil
MDT
Medtronic PLCNktvsfyFvtsxl$107.5 Bil
EW
Edwards Lifesciences CorpYqmywzhhnLmzvrl$53.0 Bil
DXCM
DexCom IncJdfgzxktVsmd$50.4 Bil
PHG
Koninklijke Philips NV ADRGtnbwmynJygnnk$25.7 Bil
ZBH
Zimmer Biomet Holdings IncCchjvpybsPct$23.9 Bil
ALGN
Align Technology IncGljxwqywyLqsbktj$19.1 Bil
PODD
Insulet CorpSzllygrrdXtcchy$12.5 Bil

Sponsor Center